Functional Characterization of the Human Factor VII 5′-Flanking Region (*)

Factor VII is a vitamin K-dependent coagulation protein essential for proper hemostasis. The human Factor VII gene spans 13 kilobase pairs and is located on chromosome 13 just 2.8 kilobase pairs 5′ to the Factor X gene. In this report, we show that Factor VII transcripts are restricted to the liver and that steady state levels of mRNA are much lower than those of Factor X. The major transcription start site is mapped at −51 by RNase protection assay and primer extension experiments. The first 185 base pairs 5′ of the translation start site are sufficient to confer maximal promoter activity in HepG2 cells. Protein binding sites are identified at nucleotides −51 to −32, −63 to −58, −108 to −84, and −233 to −215 by DNase I footprint analysis and gel mobility shift assays. A liver-enriched transcription factor, hepatocyte nuclear factor-4 (HNF-4), and a ubiquitous transcription factor, Sp1, are shown to bind within the first 108 base pairs of the promoter region at nucleotide sequences ACTTTG and CCCCTCCCCC, respectively. The importance of these binding sites in promoter activity is demonstrated through independent functional mutagenesis experiments, which show dramatically reduced promoter activity. Transactivation studies with an HNF-4 expression plasmid in HeLa cells also demonstrate the importance of HNF-4 in promoting transcription in nonhepatocyte derived cells. Additionally, the sequence of a naturally occurring allele containing a previously described decanucleotide insert polymorphism at −323 is shown to reduce promoter activity by 33% compared with the more common allelic sequence.

[1]  Gene regulation by steroid hormones , 1989, Cell.

[2]  H. Schulte,et al.  Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause , 1985, Thrombosis and Haemostasis.

[3]  D. Moore,et al.  Human growth hormone as a reporter gene in regulation studies employing transient gene expression , 1986, Molecular and cellular biology.

[4]  J. Suttie,et al.  Vitamin K-dependent carboxylase. Development of a peptide substrate. , 1976, The Journal of biological chemistry.

[5]  T. Meade,et al.  A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  K. Kario,et al.  Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  J. Darnell,et al.  Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. , 1990, Genes & development.

[8]  R. Miller,et al.  Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[10]  Robert Tjian,et al.  Mechanism of transcriptional activation by Sp1: Evidence for coactivators , 1990, Cell.

[11]  R. Saiki,et al.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.

[12]  J. Cooper,et al.  Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  K. High,et al.  Characterization of the human blood coagulation factor X promoter. , 1992, The Journal of biological chemistry.

[14]  R. Marlar,et al.  Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line. , 1986 .

[15]  Pamela F. Jones,et al.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.

[16]  P. Sharp,et al.  A single polypeptide possesses the binding and transcription activities of the adenovirus major late transcription factor , 1986, Molecular and Cellular Biology.

[17]  P. Reitsma,et al.  Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[19]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[20]  F. Grant,et al.  Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Kurachi,et al.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.

[22]  L. Guize,et al.  Factor VII activation and menopausal status. , 1990, Thrombosis research.

[23]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[24]  A. Folsom,et al.  Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.

[25]  P. Bucher Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. , 1990, Journal of molecular biology.

[26]  G. Nelsestuen Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. , 1976, The Journal of biological chemistry.

[27]  L. Kedes,et al.  Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter , 1989, Molecular and cellular biology.

[28]  C. Jamison,et al.  Prenatal and postnatal expression of mRNA coding for rat prothrombin. , 1991, Biochimica et biophysica acta.

[29]  E. Davie,et al.  Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. , 1992, Journal of Biological Chemistry.

[30]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[31]  B. Furie,et al.  The molecular basis of blood coagulation , 1988, Cell.

[32]  J. Bonnar Coagulation effects of oral contraception. , 1987, American journal of obstetrics and gynecology.

[33]  R. Cortese,et al.  Two distinct factors interact with the promoter regions of several liver‐specific genes. , 1988, The EMBO journal.

[34]  D. Fair Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. , 1983 .

[35]  J. Francis Molecular Basis of Thrombosis and Hemostasis , 1996 .

[36]  U. Schibler,et al.  Tissue-specific in vitro transcription from the mouse albumin promoter , 1986, Cell.

[37]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[39]  J. Y. Chen,et al.  Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. , 1993, The Journal of biological chemistry.

[40]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[41]  C. Jiang,et al.  Start site selection by Sp1 in the TATA-less human Ha-ras promoter. , 1994, The Journal of biological chemistry.

[42]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[43]  Oxon Dm Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[44]  D. Baltimore,et al.  The “initiator” as a transcription control element , 1989, Cell.

[45]  B. Osterud,et al.  Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. , 1979, Blood.

[46]  M. Adesnik,et al.  Construction of mutant and chimeric genes using the polymerase chain reaction. , 1989, Nucleic acids research.

[47]  S. Smale,et al.  DNA sequence requirements for transcriptional initiator activity in mammalian cells. , 1994, Molecular and cellular biology.

[48]  H. Roberts,et al.  New perspectives on the coagulation cascade. , 1992, Hospital practice.

[49]  J. Azizkhan,et al.  Transcription from TATA-less promoters: dihydrofolate reductase as a model. , 1993, Critical reviews in eukaryotic gene expression.

[50]  K. High,et al.  Molecular Basis of Thrombosis and Hemostasis , 1995 .

[51]  C. Bonithon-Kopp,et al.  Relationship between sex hormones and haemostatic factors in healthy middle-aged men. , 1988, Atherosclerosis.

[52]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Ueli Schibler,et al.  The interplay of DNA-binding proteins on the promoter of the mouse albumin gene , 1987, Cell.